UnicoCell Biomed Co., Ltd.(TW:6794)
NT$64.80+0.30 (+0.47%)
TW:6794
UnicoCell Biomed Co., Ltd. financials statements
NT$64.80
At close:+0.30 (+0.47%)
UnicoCell Biomed Co., Ltd. (6794) Income Statement
UnicoCell Biomed Co., Ltd. Income Statement
Last quarter (Q4 2025), UnicoCell Biomed Co., Ltd.'s total revenue was NT$12.77M, an increase of 0.79% from the same quarter last year. In Q4, UnicoCell Biomed Co., Ltd.'s net income was NT$-51.84M. See UnicoCell Biomed Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 30.10M | NT$ 31.88M | NT$ 24.59M | NT$ 14.40M | NT$ 8.18M | |
| NT$ -221.00K | NT$ 20.57M | NT$ 17.90M | NT$ 8.20M | NT$ 5.83M | |
| NT$ 130.06M | NT$ 123.49M | NT$ 114.18M | NT$ 100.31M | NT$ 93.17M | |
| Depreciation and Amortization | NT$ 20.55M | NT$ 27.58M | NT$ 26.38M | NT$ 24.27M | NT$ 26.27M |
| NT$ -109.73M | NT$ -64.03M | NT$ -56.28M | NT$ -65.63M | NT$ -59.45M | |
| NT$ -130.28M | NT$ -102.92M | NT$ -96.28M | NT$ -92.11M | NT$ -87.34M | |
| NT$ 15.44M | NT$ 9.85M | NT$ 12.17M | NT$ 954.00K | NT$ 963.00K | |
| NT$ -114.84M | NT$ -93.07M | NT$ -84.11M | NT$ -91.16M | NT$ -86.37M | |
| NT$ -114.84M | NT$ -93.07M | NT$ -84.11M | NT$ -91.16M | NT$ -86.37M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.89 | NT$ -1.57 | NT$ -1.56 | NT$ -2.20 | NT$ -2.29 |
| Diluted EPS | NT$ -1.89 | NT$ -1.57 | NT$ -1.56 | NT$ -2.20 | NT$ -2.29 |
| Weighted Average Shares Outstanding | 60.90M | 59.35M | 53.92M | 41.43M | 37.68M |
| Weighted Average Shares Outstanding (Diluted) | 60.90M | 59.35M | 53.92M | 41.50M | 37.68M |
Currency in TWD

